Calvert Investment Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,138
Closed -$409K 366
2016
Q4
$409K Buy
6,138
+40
+0.7% +$2.6K 0.02% 589
2016
Q3
$404K Buy
6,098
+448
+8% +$30.6K 0.01% 584
2016
Q2
$409K Buy
5,650
+444
+9% +$30.5K 0.02% 551
2016
Q1
$336K Buy
5,206
+192
+4% +$12.7K 0.01% 572
2015
Q4
$359K Buy
5,014
+1,145
+30% +$84.7K 0.02% 522
2015
Q3
$297K Buy
3,869
+156
+4% +$12.6K 0.01% 477
2015
Q2
$275K Sell
3,713
-741
-17% -$53.3K 0.01% 529
2015
Q1
$323K Buy
4,454
+742
+20% +$51.6K 0.02% 480
2014
Q4
$245K Buy
3,712
+42
+1% +$2.56K 0.02% 513
2014
Q3
$201K Buy
+3,670
New +$208K 0.01% 552

Other funds holding MD

Calvert Investment Management's MD Position: Q1 2017 in Review

Calvert Investment Management sold out of Pediatrix Medical (MD) in Q1 2017, closing a stake of 6,138 shares — an estimated $409K sold.

Calvert Investment Management first reported a position in MD in Q3 2014 and held it in 10 quarters. The position peaked at $409K in Q4 2016. 359 funds tracked by Wall St. Rank hold MD as of Q1 2017.

  • Calvert Investment Management reported no remaining Pediatrix Medical position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 6,138 Pediatrix Medical shares in Q1 2017, an estimated $409K.
  • Calvert Investment Management first reported a position in Pediatrix Medical in Q3 2014 and held it in 10 quarters.
  • Calvert Investment Management's Pediatrix Medical position peaked at $409K in Q4 2016.
  • 359 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.